ADAP
Adaptimmune Therapeutics
ADAP
ADAP
Delisted
ADAP was delisted on the 27th of October, 2025.
49 hedge funds and large institutions have $250M invested in Adaptimmune Therapeutics in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
49
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$34.8M | |
| 2 | +$21.4M | |
| 3 | +$8.04M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.03M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$12M | |
| 3 | -$7.84M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.42M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$1.33M |